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Abstract
Cardiovascular implantable electronic devices (CIEDs) are frequently related to endocarditis. Most cases of intravascular CIED infections
are usually related to skin ﬂora, but a few cases may occur with negative blood culture. Coxiella burnetii is one of the main causes of
blood culture-negative endocarditis in native and prosthetic valves, but to date no cases related to CIED have been published. Herein
we report two cases of Q fever endocarditis related to these non-valvular cardiovascular devices.
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Abstract
We have studied transmitted drug resistance (TDR) in 1.864 antiretroviral-naı¨ve patients entering CoRIS (Spain) during 2007–2010. An
overall 8.58% TDR was observed (3.92%, nucleoside reverse transcriptase inhibitors (NRTIs); 3.86%, non-nucleoside reverse transcrip-
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tase inhibitors (NNRTIs); 2.31%, protease inhibitors), with a signiﬁcant decreasing trend over time for NNRTIs (5.53%, 2007; 2.45%,
2010; p for trend = 0.044). Non-B subtype prevalence was 15.93%, with a signiﬁcant increase (11.95%, 2007; 18.14%, 2010; p for
trend = 0.018), mainly related to immigration. Having no formal education increased the risk of TDR to NNRTIs (OR, 7.26), and carry-
ing a non-B subtype reduced the risk of TDR to NRTIs (OR, 0.27). These ﬁndings may have important implications for treatment guide-
lines and laboratory testing recommendations.
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